Pharmacometabolomics of trabectedin in metastatic soft tissue sarcoma patients

Objective: Trabectedin is an anti-cancer drug commonly used for the treatment of patients with metastatic soft tissue sarcoma (mSTS). Despite its recognized efficacy, significant variability in pharmacological response has been observed among mSTS patients. To address this issue, this pharmacometabo...

Descripción completa

Detalles Bibliográficos
Autores principales: Corona, Giuseppe, Di Gregorio, Emanuela, Buonadonna, Angela, Lombardi, Davide, Scalone, Simona, Steffan, Agostino, Miolo, Gianmaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450632/
https://www.ncbi.nlm.nih.gov/pubmed/37637412
http://dx.doi.org/10.3389/fphar.2023.1212634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450632/
https://www.ncbi.nlm.nih.gov/pubmed/37637412
http://dx.doi.org/10.3389/fphar.2023.1212634

Ejemplares similares